The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
暂无分享,去创建一个
P. Sexton | A. Christopoulos | C. Reynolds | L. Miller | J. Simms | P. Thompson | J. Mobarec | D. Wootten | C. Koole | Mengjie Liu | K. Pabreja | Sebastian G. B. Furness | Kevin J. Smith | E. Savage | Rohan Sridhar | S. G. Furness | C. Reynolds | Cassandra Koole | Kavita Pabreja
[1] P. Sexton,et al. A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures , 2016, Molecular Pharmacology.
[2] R. Lerner,et al. Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects , 2015, Nature Communications.
[3] A. Mathiowetz,et al. Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists. , 2015, Journal of medicinal chemistry.
[4] Han Choe,et al. Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain* , 2015, The Journal of Biological Chemistry.
[5] Andrej Sali,et al. Comparative Protein Structure Modeling Using MODELLER , 2014, Current protocols in bioinformatics.
[6] Lei Wang,et al. Genetically Encoded Chemical Probes in Cells Reveal the Binding Path of Urocortin-I to CRF Class B GPCR , 2013, Cell.
[7] David E. Gloriam,et al. GPCRDB: an information system for G protein-coupled receptors , 2013, Nucleic Acids Res..
[8] Graham J. G. Upton,et al. Do Plants Contain G Protein-Coupled Receptors?1[C][W][OPEN] , 2013, Plant Physiology.
[9] T. Reid. Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Primary Care , 2013, Clinical Diabetes.
[10] Chris de Graaf,et al. Structure of the human glucagon class B G-protein-coupled receptor , 2013, Nature.
[11] Ali Jazayeri,et al. Structure of class B GPCR corticotropin-releasing factor receptor 1 , 2013, Nature.
[12] Woody Sherman,et al. Improved Docking of Polypeptides with Glide , 2013, J. Chem. Inf. Model..
[13] P. Sexton,et al. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands , 2013, Molecular Pharmacology.
[14] Arthur Christopoulos,et al. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations , 2013, Proceedings of the National Academy of Sciences.
[15] Bruck Taddese,et al. Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies , 2013, Journal of The Royal Society Interface.
[16] R. Stevens,et al. Structure-function of the G protein-coupled receptor superfamily. , 2013, Annual review of pharmacology and toxicology.
[17] Ruben Abagyan,et al. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] I. Hötzel,et al. Molecular basis for negative regulation of the glucagon receptor , 2012, Proceedings of the National Academy of Sciences.
[19] Arthur Christopoulos,et al. Signalling bias in new drug discovery: detection, quantification and therapeutic impact , 2012, Nature Reviews Drug Discovery.
[20] Kuntal Pal,et al. Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors , 2012, Acta Pharmacologica Sinica.
[21] P. Sexton,et al. Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation* , 2011, The Journal of Biological Chemistry.
[22] D. Poyner,et al. Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function , 2011, Biochimica et biophysica acta.
[23] Ruben Abagyan,et al. Refinement of Glucagon-like Peptide 1 Docking to Its Intact Receptor Using Mid-region Photolabile Probes and Molecular Modeling* , 2011, The Journal of Biological Chemistry.
[24] P. Sexton,et al. Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening , 2010, Molecular Pharmacology.
[25] K. Coopman,et al. Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent “Compound 2” at the GLP-1 Receptor , 2010, Journal of Pharmacology and Experimental Therapeutics.
[26] Laurence J Miller,et al. Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor , 2010, The Journal of Biological Chemistry.
[27] Lotte Bjerre Knudsen,et al. Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor* , 2009, The Journal of Biological Chemistry.
[28] Laurence J Miller,et al. Molecular Basis of Glucagon-like Peptide 1 Docking to Its Intact Receptor Studied with Carboxyl-terminal Photolabile Probes* , 2009, The Journal of Biological Chemistry.
[29] M J Harvey,et al. ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. , 2009, Journal of chemical theory and computation.
[30] D. Drucker,et al. Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.
[31] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[32] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[33] A. Sali,et al. Statistical potential for assessment and prediction of protein structures , 2006, Protein science : a publication of the Protein Society.
[34] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[35] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[36] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[37] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[38] P. Robberecht,et al. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC2: role of basic residues in the second transmembrane helix , 2001, British journal of pharmacology.
[39] P. Robberecht,et al. Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction* , 2001, The Journal of Biological Chemistry.
[40] L A Kelley,et al. OLDERADO: On‐line database of ensemble representatives and domains , 1997, Protein science : a publication of the Protein Society.
[41] H. Jüppner,et al. Residues in the Membrane-spanning and Extracellular Loop Regions of the Parathyroid Hormone (PTH)-2 Receptor Determine Signaling Selectivity for PTH and PTH-related Peptide* , 1997, The Journal of Biological Chemistry.
[42] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[43] L. Kelley,et al. An automated approach for defining core atoms and domains in an ensemble of NMR-derived protein structures. , 1997, Protein engineering.
[44] L. B. Knudsen,et al. Structure-activity studies of glucagon-like peptide-1. , 1994, The Journal of biological chemistry.
[45] J. Black,et al. Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[46] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[47] A. Couvineau,et al. The family B1 GPCR: structural aspects and interaction with accessory proteins. , 2012, Current drug targets.
[48] A. Bairoch,et al. GPCRDB: an information system for G protein-coupled receptors , 1998, Nucleic Acids Res..